Detection of liver injury in IBD using transient elastography

Journal of Crohn's and Colitis

Volumn 8, Issue 7, 2014, Pages 671-677

  Thin, L W Y ^a   Lawrance, I C ^a,b   Spilsbury, K ^c   Kava, J ^a   Olynyk, J K ^a,d,e  

^a FREMANTLE HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c CURTIN UNIVERSITY   (Australia)

^d CURTIN UNIVERSITY   (Australia)

^e MURDOCH UNIVERSITY   (Australia)

Author keywords

IBD; Liver stiffness; NAFLD; Transient elastography

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; CROSS-SECTIONAL STUDY; ELASTOGRAPH; ELASTOGRAPHY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER INJURY; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE BLIND PROCEDURE; TRANSIENT ELASTOGRAPHY; ULCERATIVE COLITIS; ANTAGONISTS AND INHIBITORS; COLITIS, ULCERATIVE; COMPLICATION; ECHOGRAPHY; LIVER DISEASES; MIDDLE AGED; PREVALENCE;

ADULT; AGE FACTORS; BODY MASS INDEX; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901494286     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.12.006     Document Type: Article

References (22)

1. Loftus E.V., Sandborn W.J., Lindor K.D., Larusso N.F. Interactions between chronic liver disease and inflammatory bowel disease. Inflamm Bowel Dis 1997, 3:288-302.
2. Gisbert J.P., Gonzalez-Lama Y., Mate J. Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review. Am J Gastroenterol 2007, 102:1518-1527.
3. Broome U., Glaumann H., Hellers G., Nilsson B., Sorstad J., Hultcrantz R. Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm. Gut 1994, 35:84-89.
4. Navaneethan U., Remzi F.H., Nutter B., Fazio V.W., Shen B. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease. Am J Gastroenterol 2009, 104:2467-2475.
5. de Boer N.K., Mulder C.J., van Bodegraven A.A. Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity. Liver Transpl 2005, 11:1300-1301.
6. Ferlitsch A., Teml A., Reinisch W., Ulbrich G., Wrba F., Homoncik M., et al. 6-Thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension. Am J Gastroenterol 2007, 102:2495-2503.
7. Mendes F.D., Levy C., Enders F.B., Loftus E.V., Angulo P., Lindor K.D. Abnormal hepatic biochemistries in patients with inflammatory bowel disease. Am J Gastroenterol 2007, 102:344-350.
8. Loras C, Gisbert JP, Minguez M, Merino O, Bujanda L, Saro C, et al. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut;59:1340-6.
9. Ghabril M., Bonkovsky H.L., Kum C., Davern T., Hayashi P.H., Kleiner D.E., et al. Liver injury from tumor necrosis factor-alpha antagonists: analysis of thirty-four cases. Clin Gastroenterol Hepatol 2013, 11:558-64 e3.
10. Smyth C., Kelleher D., Keeling P.W. Hepatic manifestations of gastrointestinal diseases. Inflammatory bowel disease, celiac disease, and Whipple's disease. Clin Liver Dis 2002, 6:1013-1032.
11. Fournier MR, Klein J, Minuk GY, Bernstein CN. Changes in liver biochemistry during methotrexate use for inflammatory bowel disease. The American journal of gastroenterology;105:1620-6.
12. Lewis J.H., Schiff E. Methotrexate-induced chronic liver injury: guidelines for detection and prevention. The ACG Committee on FDA-related matters. American College of Gastroenterology. Am J Gastroenterol 1988, 83:1337-1345.
13. Gonzalez-Lama Y., Taxonera C., Lopez-Sanroman A., Perez-Calle J.L., Bermejo F., Pajares R., et al. Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience. Eur J Gastroenterol Hepatol 2012, 24:1086-1091.
14. Castera L., Forns X., Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008, 48:835-847.
15. Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology;51:454-62.
16. Barbero-Villares A., Mendoza Jimenez-Ridruejo J., Taxonera C., Lopez-Sanroman A., Pajares R., Bermejo F., et al. Evaluation of liver fibrosis by transient elastography (Fibroscan(R)) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial. Scand J Gastroenterol 2012, 47:575-579.
17. Laharie D., Zerbib F., Adhoute X., Boue-Lahorgue X., Foucher J., Castera L., et al. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate. Aliment Pharmacol Ther 2006, 23:1621-1628.
18. Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990, 11:272-276.
19. McGowan C.E., Jones P., Long M.D., Barritt A.S.t. Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literature. Inflamm Bowel Dis 2012, 18:49-54.
20. Zein C.O., Unalp A., Colvin R., Liu Y.C., McCullough A.J. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol 2011, 54:753-759.
21. Tilg H., Day C.P. Management strategies in alcoholic liver disease. Nat Clin Pract Gastroenterol Hepatol 2007, 4:24-34.
22. Koca S.S., Bahcecioglu I.H., Poyrazoglu O.K., Ozercan I.H., Sahin K., Ustundag B. The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Inflammation 2008, 31:91-98.